secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2024-12-26T23:59:59+00:00
Accession:  0001104659-24-131554
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharmaceuticals prices $6.8M public offering of ADSs and warrants
-----------------------------------------------------------------------

- Gross proceeds ~$6.8M from offering of 15,111,110 ADSs (or pre-funded warrants) and Series F/G warrants at $0.45 per unit.
- Series F warrants (2-yr expiry) and Series G warrants (5-yr expiry) each have exercise price of $0.45 per ADS.
- Prior warrants for up to 7,002,500 ADSs amended: exercise price reduced to $0.45 from $1.60, expiry extended to Dec 2029.
- Company officers and directors purchased ~$600K of ADSs and warrants in the offering.
- Net proceeds to be used for general corporate purposes, including R&D and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924131554/0001104659-24-131554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924131554/tm2430640d5_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-131554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer